TrueShares Structured Outcome (February) ETF (BATS:FEBZ) Shares Up 0.1%
Shares of TrueShares Structured Outcome (February) ETF (BATS:FEBZ – Get Rating) shot up 0.1% during mid-day trading on Monday . The company traded as high as $27.64 and last traded at $27.64. 500 shares traded hands during mid-day trading, The stock had previously closed at $27.62.
TrueShares 结构性收益（2月）可交易ETF（BATS:FEBZ – 获取评级）在周一的中午交易中上涨了0.1%。该公司最高交易价格为27.64美元，最后交易价格为27.64美元。中午交易中交易了500股，该股票之前的收盘价为27.62美元。
TrueShares Structured Outcome (February) ETF Stock Down 0.1 %
TrueShares 结构性收益（2月）可交易ETF 股票下跌0.1%
The company has a fifty day moving average of $26.29 and a 200 day moving average of $26.57.
该公司的50日移动平均线为26.29美元，200日移动平均线为26.57美元。
Hedge Funds Weigh In On TrueShares Structured Outcome (February) ETF
对TrueShares 结构性收益（2月）可交易ETF的对冲基金进行评估
Large investors have recently bought and sold shares of the business. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of TrueShares Structured Outcome (February) ETF in the first quarter valued at approximately $722,000. OLD Mission Capital LLC grew its stake in TrueShares Structured Outcome (February) ETF by 246.0% in the 2nd quarter. OLD Mission Capital LLC now owns 28,286 shares of the company's stock valued at $728,000 after acquiring an additional 20,110 shares during the period. Finally, Castleview Partners LLC increased its holdings in TrueShares Structured Outcome (February) ETF by 10.6% in the 2nd quarter. Castleview Partners LLC now owns 13,101 shares of the company's stock worth $327,000 after acquiring an additional 1,259 shares in the last quarter.
大型投资者最近买入和卖出了该业务的股份。剑桥投资研究顾问公司在第一季度购买了TrueShares结构性结果（2月）可交易ETF的新股份，价值约为722,000美元。OLD Mission Capital LLC在第二季度将对TrueShares结构性结果（2月）可交易ETF的股份增加了246.0%。OLD Mission Capital LLC现在拥有28,286股该公司的股票，价值为728,000美元，在此期间再购买了20,110股。最后，Castleview Partners LLC在第二季度将对TrueShares结构性结果（2月）可交易ETF的持股增加了10.6%。Castleview Partners LLC现在拥有13,101股该公司的股票，价值为327,000美元，在上一季度额外购买了1,259股。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on TrueShares Structured Outcome (February) ETF (FEBZ)
- Hormel: Is This The Time To Buy?
- Struggling Axsome Stock Could Bounce Back on Drug Trial Success
- Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
- Three Reasons It's Time To Get Bullish On Organigram
- Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
- 获取TrueShares结构性结果（2月）可交易ETF（FEBZ）在StockNews.com上的研究报告的免费副本
- 荷姆尔：现在购买还为时过早吗？
- 处于困境的Axsome股票可能会因药物试验成功而反弹
- 哪些股票是黑色星期五和网络星期一的赢家和输家？
- 三大理由让我们看好OrganiGram
- 机会来了！Hibbett, Inc在强劲业绩下表现平平
Receive News & Ratings for TrueShares Structured Outcome (February) ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueShares Structured Outcome (February) ETF and related companies with MarketBeat.com's FREE daily email newsletter.
接收TrueShares结构性结果（2月）可交易ETF的资讯和评级 - 在下面输入您的电子邮件地址，以接收MarketBeat.com提供的免费每日电子邮件通讯，其中包含TrueShares结构性结果（2月）可交易ETF及相关公司的最新资讯和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。
